CIK: 0001807489 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 13, 2024
Total Value ($000): $77,140 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 6,164,548 | $30,761 | 39.9% | $3.40 | +67.9% | SHS | Y95308105 |
| IVVD | INVIVYD INC | 9,248,250 | $10,173 | 13.2% | $17.64 | -87.5% | COM | 00534A102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 385,680 | $8,304 | 10.8% | $23.75 | -3.3% | COM | 77313F106 |
| GUTS | FRACTYL HEALTH INC | 1,856,117 | $7,926 | 10.3% | $8.42 | -23.6% | COM | 35168W103 |
| — | SPRINGWORKS THERAPEUTICS INC | 110,400 | $4,159 | 5.4% | $25.89 | — | COM | 85205L107 |
| SLN | SILENCE THERAPEUTICS PLC | 185,100 | $3,517 | 4.6% | $9.41 | — | ADS | 82686Q101 |
| BBIO | BRIDGEBIO PHARMA INC | 121,200 | $3,070 | 4.0% | $39.38 | -30.6% | COM | 10806X102 |
| CRIS | CURIS INC | 421,951 | $2,911 | 3.8% | $12.87 | -3.3% | COM | 231269309 |
| TGTX | TG THERAPEUTICS INC | 161,600 | $2,875 | 3.7% | $15.49 | +3.0% | COM | 88322Q108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $1,752 | 2.3% | $33.13 | -25.8% | COM | 04280A100 |
| PRQR | PROQR THRAPEUTICS N V | 1,019,498 | $1,692 | 2.2% | $2.38 | -18.4% | SHS EURO | N71542109 |